Skip to content
Screener

Liquidia Corporation LQDA Investing Cash Flow

Investing Cash Flow at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
-$203M+35.4%
Mannkind logo
MannkindMNKD
$17.91M+186%
United Therapeutics logo
United TherapeuticsUTHR
$87.5M+129%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$159.99M-2,324%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$52.59M+71.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$42.74M-2,579%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash provided by (used in) operating activities52,990(30,679)
Investing activities
Purchases of property, plant and equipment(2,830)(330)
Net cash used in investing activities(2,830)(330)
Financing activities
Proceeds from long-term debt, net of fees24,975
Payments on long-term debt(19,969)(2,122)
Principal payments on finance leases(64)

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's investing cash flow?
Liquidia Corporation (LQDA) reported investing cash flow of -$2.83M in Q1 2026.
How has Liquidia Corporation's investing cash flow changed year-over-year?
Liquidia Corporation's investing cash flow decreased by 757.6% year-over-year, from -$330K to -$2.83M.
What is the long-term trend for Liquidia Corporation's investing cash flow?
Over 4 years (2021 to 2025), Liquidia Corporation's investing cash flow has grown at a 177.4% compound annual growth rate (CAGR), from -$107K to -$6.34M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Liquidia Corporation's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude